John F. Crowley - 28 Oct 2021 Form 3 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Director
Signature
/s/ Jared Cohen, as Attorney-in-fact
Issuer symbol
TRDA
Transactions as of
28 Oct 2021
Net transactions value
$0
Form type
3
Filing time
28 Oct 2021, 20:55:45 UTC
Previous filing
18 Oct 2021
Next filing
03 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TRDA Common Stock 32,864 28 Oct 2021 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TRDA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 14,180 $8.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 19,170 shares of common stock and (ii) 13,694 shares of restricted common stock issued upon early exercise of stock options held by John F. Crowley 2021 Family Trust. John F. Crowley exercises voting and dispositive power over the shares beneficially owned by John F. Crowley 2021 Family Trust.
F2 The shares subject to this option shall vest and become exercisable in 48 equal monthly installments, commencing on March 30, 2021 (the "Vesting Start Date"), such that the option shares will be fully vested on the four-year anniversary of the Vesting Start Date.

Remarks:

Exhibit 24 - Power of Attorney